| Nome |
# |
|
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test, file e3aa200b-8aff-ebae-e053-6605fe0a5b79
|
2
|
|
Treatment with ACE inhibitors is associated with a reduction in short term mortality in older patients with severe acute ischemic stroke, file e3aa200d-e28d-ebae-e053-6605fe0a5b79
|
2
|
|
CSF monoamine metabolites in old age dementias., file e3aa200e-e145-ebae-e053-6605fe0a5b79
|
2
|
|
Elderly patients with cognitive impairment have a high risk for functinal decline during hospitalization: The GIFA Study, file e3aa2010-05e6-ebae-e053-6605fe0a5b79
|
2
|
|
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group, file e3aa200b-3663-ebae-e053-6605fe0a5b79
|
1
|
|
Axonal injury within language network in primary progressive aphasia, file e3aa200b-3cee-ebae-e053-6605fe0a5b79
|
1
|
|
Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study, file e3aa200b-3cf5-ebae-e053-6605fe0a5b79
|
1
|
|
Hypertension and Cognitive Function in the Elderly., file e3aa200b-3cf6-ebae-e053-6605fe0a5b79
|
1
|
|
Pharmaceutical treatment of cognitive disorders in Alzheimer's disease., file e3aa200b-8b0e-ebae-e053-6605fe0a5b79
|
1
|
|
The effects of aging and endurance exercise on cardiovascular performance in healthy elderly: a review of the literature., file e3aa200b-8d0f-ebae-e053-6605fe0a5b79
|
1
|
|
Is multi-infarct dementia representative of vascular dementias? A retrospective study, file e3aa200e-ce5e-ebae-e053-6605fe0a5b79
|
1
|
|
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type, file e3aa200e-cf55-ebae-e053-6605fe0a5b79
|
1
|
|
Tau protein in cerebrospinal fluid: a new diagnostic and prognostic marker in Alzheimer disease?, file e3aa200e-d715-ebae-e053-6605fe0a5b79
|
1
|
|
Oxidative stress and lymphocytes in Alzheimer disease., file e3aa200e-d720-ebae-e053-6605fe0a5b79
|
1
|
|
Plasma lipid peroxidation and vitamin C status in healthy centenarians., file e3aa200e-d7b0-ebae-e053-6605fe0a5b79
|
1
|
|
Plasma antioxidants and longevity: a study on healthy centenarians., file e3aa200e-d89b-ebae-e053-6605fe0a5b79
|
1
|
|
Impact of the earthquake of September 26, 1997 in Umbria, Italy on the socioenvironmental and psychophysical conditions of an elderly population, file e3aa200e-d9d0-ebae-e053-6605fe0a5b79
|
1
|
|
Plasma levels of lipophilic antioxidants in very old subjects with type 2 diabetes, file e3aa200e-dab4-ebae-e053-6605fe0a5b79
|
1
|
|
Mithocondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain, file e3aa200e-df32-ebae-e053-6605fe0a5b79
|
1
|
|
Blood-brain-barrier in a geriatric population: barrier function in degenerative and vascular dementias., file e3aa200e-e04d-ebae-e053-6605fe0a5b79
|
1
|
|
Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type., file e3aa200e-e051-ebae-e053-6605fe0a5b79
|
1
|
|
Serum autoantibodies against glial fibrillary acidic protein in brain aging and senile dementias, file e3aa200e-e149-ebae-e053-6605fe0a5b79
|
1
|
|
Cognitive enhancement therapy for Alzheimer's disease. The way forward., file e3aa200e-e14f-ebae-e053-6605fe0a5b79
|
1
|
|
Increased oxidative damage in lymphocytes of Alzheimer disease patients. (Letter), file e3aa200e-e1cf-ebae-e053-6605fe0a5b79
|
1
|
|
Pathogenetic mechanisms in vascular dementia, file e3aa200e-e274-ebae-e053-6605fe0a5b79
|
1
|
|
Autoantibodies against oxidized low-density lipoproteins in older stroke patients. (Letter), file e3aa200e-e385-ebae-e053-6605fe0a5b79
|
1
|
|
Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia., file e3aa200e-e3f3-ebae-e053-6605fe0a5b79
|
1
|
|
Altered mitochondrial membrane fluidity in AD brain., file e3aa200e-e3fb-ebae-e053-6605fe0a5b79
|
1
|
|
Dementia, depression and parkinsonism: A frequent association in the elderly., file e3aa200f-cb35-ebae-e053-6605fe0a5b79
|
1
|
|
Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease., file e3aa200f-cdfd-ebae-e053-6605fe0a5b79
|
1
|
|
Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease., file e3aa200f-dd23-ebae-e053-6605fe0a5b79
|
1
|
|
Superficial siderosis of the central nervous system: a 70-year-old man with ataxia, depression and visual deficits, file e3aa200f-dfbc-ebae-e053-6605fe0a5b79
|
1
|
|
Validation of the five-item geriatric depression scale in elderly subjects in three different settings., file e3aa200f-e341-ebae-e053-6605fe0a5b79
|
1
|
|
The brain of the elderly between normality and pathology: Techniques and technologies for the evaluation, file e3aa200f-e343-ebae-e053-6605fe0a5b79
|
1
|
|
Neuropsychological assessment of the severely impaired elderly patient: validation of the Italian short version of the Severe Impairment Battery (SIB)., file e3aa200f-e34b-ebae-e053-6605fe0a5b79
|
1
|
|
Role of antioxidants in atherosclerosis: epidemiological and clinical update, file e3aa200f-e9af-ebae-e053-6605fe0a5b79
|
1
|
|
Impact of population aging on the social and the health care system: need for a new model of long-term care, file e3aa200f-ed50-ebae-e053-6605fe0a5b79
|
1
|
|
Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease., file e3aa200f-ee23-ebae-e053-6605fe0a5b79
|
1
|
|
Rapidly progressive aphasic dementia with motor neuron disease: A distinctive clinical entity, file e3aa200f-ee29-ebae-e053-6605fe0a5b79
|
1
|
|
Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome., file e3aa200f-ee2d-ebae-e053-6605fe0a5b79
|
1
|
|
Age and sex influence on oxidative damage and functional status in human skeletal muscle., file e3aa200f-f4d9-ebae-e053-6605fe0a5b79
|
1
|
|
Heart disease and vascular risk factors in the cognitively impaired elderly: implications for Alzheimer's dementia, file e3aa200f-f4dc-ebae-e053-6605fe0a5b79
|
1
|
|
H-1-MR spectroscopy differentiates mild cognitive impairment from normal brain aging, file e3aa200f-f4dd-ebae-e053-6605fe0a5b79
|
1
|
|
Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation: results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) Study., file e3aa200f-f5c2-ebae-e053-6605fe0a5b79
|
1
|
|
Hyperhomocysteinemia and oxidative stress in ischemic stroke, file e3aa200f-f783-ebae-e053-6605fe0a5b79
|
1
|
|
Predictors of high level of burden and distress in caregivers of demented patients: results of an Italian multicenter study, file e3aa2010-097e-ebae-e053-6605fe0a5b79
|
1
|
|
High basal metabolic rate is a risk factor for mortality: the Baltimore Longitudinal Study of Aging, file e3aa2010-0f30-ebae-e053-6605fe0a5b79
|
1
|
|
Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia, file e3aa2010-1116-ebae-e053-6605fe0a5b79
|
1
|
|
Depression in the elderly: new concepts and therapeutic approaches., file e3aa2010-12c4-ebae-e053-6605fe0a5b79
|
1
|
|
The Interplay Between Uric Acid and Antioxidants in Relation to Physical Function in Older Persons, file e3aa2010-1ab8-ebae-e053-6605fe0a5b79
|
1
|
|
Peripheral non-enzymatic antioxidant changes with human aging: a selective status report, file e3aa2010-21aa-ebae-e053-6605fe0a5b79
|
1
|
|
The Caregiver Burden Inventory in evaluating the burden of caregivers of elderly demented patients: results from a multicenter study, file e3aa2010-221d-ebae-e053-6605fe0a5b79
|
1
|
|
Cognitive Impairment Is the Major Risk Factor for Development of Geriatric Syndromes during Hospitalization: Results from the GIFA Study, file e3aa2010-221f-ebae-e053-6605fe0a5b79
|
1
|
|
Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years, file e3aa2010-2275-ebae-e053-6605fe0a5b79
|
1
|
|
Antioxidant profile and early outcome in stroke patients., file e3aa2010-22b6-ebae-e053-6605fe0a5b79
|
1
|
|
Use of artificial networks in clinical trials: a pilot study to predict responsiveness to donepezil in Alzheimer's disease., file e3aa2010-23d9-ebae-e053-6605fe0a5b79
|
1
|
|
Genetic factors associated with the absence of atherosclerosis in octogenarians, file e3aa2010-24bb-ebae-e053-6605fe0a5b79
|
1
|
|
Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study., file e3aa2010-3105-ebae-e053-6605fe0a5b79
|
1
|
|
Hippocampal atrophy in people with memory deficits: results from the population-based IPREA study, file e3aa2010-3581-ebae-e053-6605fe0a5b79
|
1
|
|
Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity, file e3aa2010-397f-ebae-e053-6605fe0a5b79
|
1
|
|
Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease., file e3aa2010-3981-ebae-e053-6605fe0a5b79
|
1
|
|
Guidelines for the treatment of Alzheimer’s disease from the Italian Association of Psychogeriatrics., file e3aa2010-3999-ebae-e053-6605fe0a5b79
|
1
|
| Totale |
66 |